ArticleBMC ophthalmology2026

Intravitreal methotrexate as a prophylactic strategy for proliferative vitreoretinopathy in high-risk retinal detachment.

Adrian Konstantin Luyken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.